AGF Investments LLC’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$1.46M Buy
10,930
+4,438
+68% +$675K 0.13% 159
2022
Q2
$1.01M Buy
+6,492
New +$999K 0.09% 56
2021
Q3
Sell
-1,255
Closed -$223K 448
2021
Q2
$223K Buy
1,255
+2
+0.2% +$346 0.02% 287
2021
Q1
$206K Sell
1,253
-66
-5% -$10.9K 0.02% 276
2020
Q4
$218K Sell
1,319
-12
-0.9% -$1.79K 0.03% 278
2020
Q3
$190K Sell
1,331
-5,951
-82% -$738K 0.02% 330
2020
Q2
$803K Sell
7,282
-136
-2% -$15K 0.08% 278
2020
Q1
$740K Buy
7,418
+4,569
+160% +$591K 0.1% 155
2019
Q4
$425K Buy
2,849
+417
+17% +$56.7K 0.08% 326
2019
Q3
$312K Sell
2,432
-977
-29% -$131K 0.07% 326
2019
Q2
$486K Buy
3,409
+1,782
+110% +$239K 0.1% 163
2019
Q1
$233K Buy
1,627
+46
+3% +$6K 0.05% 232
2018
Q4
$196K Buy
+1,581
New +$235K 0.03% 268
2018
Q2
Sell
-35
Closed -$5K 857
2018
Q1
$5K Buy
+35
New +$5.13K ﹤0.01% 570

Other funds holding JAZZ

AGF Investments LLC's JAZZ Position: Q3 2022 in Review

AGF Investments LLC increased its Jazz Pharmaceuticals (JAZZ) stake by 68% in Q3 2022, buying an estimated $675K and bringing the position to 10,930 shares worth $1.46M. The position accounts for 0.13% of the portfolio, ranked #159.

AGF Investments LLC first reported a position in JAZZ in Q1 2018 and has held it in 14 quarters since. 468 funds tracked by Wall St. Rank hold JAZZ as of Q3 2022.

  • AGF Investments LLC held 10,930 shares of Jazz Pharmaceuticals worth $1.46M as of Q3 2022.
  • AGF Investments LLC bought 4,438 Jazz Pharmaceuticals shares in Q3 2022, an estimated $675K.
  • Jazz Pharmaceuticals made up 0.13% of AGF Investments LLC's portfolio in Q3 2022, its #159 holding.
  • AGF Investments LLC first reported a position in Jazz Pharmaceuticals in Q1 2018 and has held it in 14 quarters since.
  • 468 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2022.

Based on AGF Investments LLC's 13F filing for Q3 2022, filed 10 Nov 2022.